Background and aims: People with Parkinson's disease (PD) who carry a heterozygous GBA1 mutation (GBA‐PD) have approximately a 30% reduction in glucocerebrosidase (GCase) activity, resulting in lysosome dysfunction and accumulation of misfolded alpha synuclein (aSyn). The gene discussed is SNCA; the disease is Parkinson disease.